Abstract: A method and apparatus for controlling a game are provided. The method for controlling a game according to one embodiment includes receiving state information of one or more applications installed in a first user terminal from the first user terminal, displaying a selection screen to receive a user's selection of a target application to be controlled from among the one or more applications, and transmitting control information for controlling a state of the target application selected by the user from among the one or more applications through the selection screen to the first user terminal based on the state information.

Abstract: The present disclosure relates to a method for preparing an aglycone or hydrolyzed glycoside converted from a glycoside and, specifically, to a method for preparing an aglycone or hydrolyzed glycoside from a glycoside by converting a glycoside into an aglycone form or hydrolyzed glycoside by using a microorganism producing ?-glycosidase, and then recovering the aglycone or hydrolyzed glycoside accumulated in the cells of the microorganism.

Abstract: A method for analyzing related substances in a pharmaceutical composition containing an amphiphilic block copolymer comprising a hydrophilic block and a hydrophobic block as a polymeric drug carrier, related substances identified thereby, and a method for evaluating a pharmaceutical composition by using the same are provided. Preferably, the method comprises evaluating a polymeric micelle pharmaceutical composition, which comprises an amphiphilic block copolymer comprising a hydrophilic block (A) and a hydrophobic block (B), and paclitaxel or docetaxel as a poorly water-soluble drug, by using a compound represented by Chemical Formula 1, wherein the hydrophilic block (A) comprises one or more selected from the group consisting of polyethylene glycol or derivatives thereof, polyvinylpyrrolidone, polyvinyl alcohol, polyacrylamide and combinations thereof; and the hydrophobic block (B) is polylactide.

Abstract: A pharmaceutical composition containing a specific related compound within a specified limit and a method for preparing the same are provided.

Abstract: The present disclosure relates to a method for preparing an aglycone or hydrolyzed glycoside converted from a glycoside and, specifically, to a method for preparing an aglycone or hydrolyzed glycoside from a glycoside by converting a glycoside into an aglycone form or hydrolyzed glycoside by using a microorganism producing ?-glycosidase, and then recovering the aglycone or hydrolyzed glycoside accumulated in the cells of the microorganism.

Abstract: The present invention relates to a 2-dimensional MXene particle surface-modified with a functional group comprising a saturated or unsaturated hydrocarbon, a preparation method thereof, and a use thereof (e.g., a conductive film).

Abstract: Provided are a display device and a method of manufacturing the same. A display device includes: a first substrate and a second substrate spaced apart from and facing each other, a seal pattern on the first substrate at an edge between the first and second substrates, a gate insulating pattern including an inorganic insulating material, the gate insulating pattern directly contacting the seal pattern on the first substrate, and a protective film including an organic insulating material and including an etched groove through which the gate insulating pattern is exposed.

Abstract: A method for operating an electronic device is provided. The method includes receiving information from outside of the electronic device, identifying blocking configuration information on the received information, determining a method for blocking the received information according to the blocking configuration information, and blocking the received information based on the determined blocking method.

Abstract: A composition comprising an A-B type diblock copolymer or a B-A-B or A-B-A type triblock copolymer with enhanced micelle stability, wherein A is a hydrophilic block and B is a hydrophobic block, and a polymeric micelle composition, a drug carrier composition and a pharmaceutical composition comprising the same are provided.

Abstract: Provided are a display device and a method of manufacturing the same. A display device includes: a first substrate and a second substrate spaced apart from and facing each other, a seal pattern on the first substrate at an edge between the first and second substrates, a gate insulating pattern including an inorganic insulating material, the gate insulating pattern directly contacting the seal pattern on the first substrate, and a protective film including an organic insulating material and including an etched groove through which the gate insulating pattern is exposed.

Abstract: The present disclosure relates to a display device including a process key, and more particularly, to a process key with an improved recognition rate in a display device implementing a narrow bezel. The feature of the present disclosure is such that a process key is divided into and formed as a first key pattern made of a metal material and a second key pattern made of a black matrix material, and the process key is positioned in a green pixel area in which a green color filter pattern is provided among pixels positioned at outermost peripheries corresponding to four corners of an active area of a display panel such that a narrow bezel can be implemented and a recognition rate of the process key can also be improved. Consequently, the display panel can be accurately aligned with manufacturing equipment or other objects such that a process defect can be minimized and process efficiency cab also be improved.

Abstract: The present disclosure relates to a display device including a first substrate and a second substrate facing each other; and a first identification number (ID) pattern positioned on a first side surface of the first substrate.

Abstract: The present invention relates to a porous acupuncture needle and a method for manufacturing the same and, more specifically, to a porous acupuncture needle, which has micro-sized or nano-sized holes formed on the surface thereof to maximize the specific surface thereof, and a method for manufacturing the same.

Abstract: A method for analyzing related substances in a pharmaceutical composition containing an amphiphilic block copolymer comprising a hydrophilic block and a hydrophobic block as a polymeric drug carrier, related substances identified thereby, and a method for evaluating a pharmaceutical composition by using the same are provided.

Abstract: Disclosed are a superconducting current-limiting element for a current limiter and a method of manufacturing a superconducting current-limiting element for a current limiter, in which the current-limiting element is formed in series by stacking linear superconducting wires, or is formed in parallel by stacking superconducting wires so that one or more superconducting wires are disposed in the same layer, thus facilitating the formation of the current-limiting element in series or in parallel and obviating the use of a winding machine when manufacturing the current-limiting element.

Abstract: The present disclosure relates to a method for preparing an aglycone or hydrolyzed glycoside converted from a glycoside and, specifically, to a method for preparing an aglycone or hydrolyzed glycoside from a glycoside by converting a glycoside into an aglycone form or hydrolyzed glycoside by using a microorganism producing ?-glycosidase, and then recovering the aglycone or hydrolyzed glycoside accumulated in the cells of the microorganism.

Abstract: The present invention relates to a fragment antigen-binding (Fab) fragment specifically binding to epidermal growth factor receptor (EGFR), an expression construct for preparing the Fab fragment, a method for preparing the Fab fragment, and a pharmaceutical composition containing the Fab fragment. The Fab fragment to EGFR of the present invention is smaller than the antibody, and thus can favorably permeate into tissues or tumors and can be prepared in bacteria, resulting in low production costs. Furthermore, the Fab fragment to EGFR of the present invention has an increased in vivo half-life through pegylation.

Abstract: There is provided a display device including: a display panel including a display area consisting of a plurality of pixel areas, and a non-display area surrounding the display area; a plurality of power lines formed on the display area to supply a first voltage to the plurality of pixel areas; a first power link line connected to the plurality of first power lines, and formed on the non-display area; and a plurality of drivers connected to the display panel, and including a plurality of output pads and a plurality of first power pads, the plurality of (first) power pads disposed between the plurality of output pads and respectively connected to the plurality of first power link lines.

Abstract: A pharmaceutical composition containing a specific related compound in an amount within a specified limit and a method for preparing the same are provided.

Abstract: A pharmaceutical composition containing a specific related compound in an amount below the standard and a method for preparing the same are provided.